NTRK1 and breast carcinoma: Functional assays on MDA-MB-231 have shown that Sortilin inhibition alters cell proliferation, survival and adhesion in vitro (34) and we have shown that a ternary complex between Sortilin/TrkA/EphA2 is involved in breast cancer cells (39).